Parkinsonism, delayed chorea and dystonia caused by extrapontine myelinolysis
Objective: To describe two case reports of patients with movement disorders due to extrapontine myelinolysis. Background: Central Pontine Myelinolysis (CPM) and Extra pontine myelinolysis (EPM)…Parkinsonism secondary to mercury poisoning in a Colombian population
Objective: To describe the clinical and paraclinical characteristics of patients over 18 years of age who consulted the Neurology service of the University Hospital with…Phenotyping spasticity-associated tonic spasms: implications for therapy
Objective: To evaluate common phenotypes of tonic spasms (TS) in patients with spasticity and inform therapeutic interventions. Background: Spasticity can be associated with several hyperkinetic…Cranial functional movement disorders: Clinical features, associated conditions and precipitating factors
Objective: We aimed to examine our large series of functional movement disorder (FMD) patients where the cranial muscles were involved in order to determine their…Experiences of people with Parkinson’s disease exercising at a centre and at home
Objective: To explore the experiences of people with Parkinson’s disease (PD) of exercising in a predominantly centre-based physiotherapy program and a remotely-monitored home-based program. Background:…The Benchmark Clinic: A Comprehensive Care Model for People with Parkinson’s Disease
Objective: To determine whether an interdisciplinary one-stop care model improves (1) patient engagement and (2) patient outcomes for people with Parkinson's disease (PwP). Background: PwP…Implementation of computer game technologies for patients with ataxia due to post-traumatic head injury: Randomized controlled trial
Objective: Up to 85 % of patients with post-traumatic brain injury suffer motor discoordination, ataxia and dyspraxia. The formation of the correct movement patterns, improved…Health care provision and health related quality of life in late stage Parkinson’s disease
Objective: To describe and assess factors associated with health related quality of life (HRQoL) in late stage Parkinson’s disease (PD), with a special focus on…A translational approach to determine target concentrations of MIN-102 (leriglitazone) to support a Phase II study in Friedreich’s ataxia
Objective: To determine efficacious plasma concentration of leriglitazone from preclinical models of Friedreich´s ataxia (FRDA). To confirm CNS target engagement in a first-in human study.…Toward the digitization of the International Parkinson and Movement Disorder Society rating scales
Objective: Create recommendations for the electronic use of rating scales (e-scaled) owned or managed by the International Parkinson and Movement Disorder Society (MDS). Background: Medicine…
- « Previous Page
- 1
- …
- 71
- 72
- 73
- 74
- 75
- …
- 149
- Next Page »